EMLA Side Effects

6878006-2 | Methaemoglobinaemia, Overdose
on Jul 19, 2010 Male patient from SPAIN , 30 years of age, was diagnosed with depilation and was treated with Emla (View Usage). Patient experienced the following unwanted or unexpected effects: methaemoglobinaemia, overdose. Emla dosage: . Patient was hospitalized.

6698274-X | Arrhythmia, Bladder Disorder, Dizziness, Gastrointestinal Disorder, Nausea, Pain Of Skin, Palpitations, Vulvovaginal Pain, Weight Decreased
Patient was taking Emla (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), bladder disorder, dizziness (What is dizziness?), gastrointestinal disorder, nausea (What is nausea?), pain of skin, palpitations, vulvovaginal pain, weight decreased on Apr 20, 2010 from CANADA Additional patient health information: Female patient , 41 years of age, weighting 120.2 lb, . Emla dosage: .

6696268-1 | Cyanosis, Dizziness, Dyspnoea
Adverse event was reported on Apr 19, 2010 by a Female patient taking Emla (View Usage) (Dosage: ) was diagnosed with depilation, anaemia and. Location: SPAIN , 40 years of age, weighting 121.3 lb, After Emla was administered, patient had the following side effects: cyanosis, dizziness (What is dizziness?), dyspnoea. During the same period patient was treated with IRON I.N.N. (View Iron I.n.n. Review and Iron I.n.n. Label ).

6660625-X | Heart Rate Decreased
on Mar 17, 2010 Male patient from FRANCE , weighting 18.30 lb, was diagnosed with local anaesthesia, nuclear magnetic resonance imaging and was treated with Emla (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate decreased. Emla dosage: 4 Patches On Elbow Fold And Hand. During the same period patient was treated with DOTAREM (View Dotarem Review and Dotarem Label ), LARGACTIL (View Largactil Review and Largactil Label ), MEOPA (Inhalation For 15 Mins) (View Meopa Review and Meopa Label ). Patient was hospitalized.


6652878-9 | Heart Rate Increased
on Mar 17, 2010 Male patient from FRANCE , weighting 18.30 lb, was diagnosed with local anaesthesia, nuclear magnetic resonance imaging and was treated with Emla (View Usage). Patient had the following side effects: heart rate increased. Emla dosage: 4 Patches On Elbow Fold And Hand. During the same period patient was treated with DOTAREM (View Dotarem Review and Dotarem Label ), LARGACTIL (View Largactil Review and Largactil Label ), MEOPA (Inhalation For 15 Mins) (View Meopa Review and Meopa Label ). Patient was hospitalized.

6427853-X | Abortion Missed, Abortion Spontaneous, Blighted Ovum
Patient was taking Emla (View Usage). After Emla was administered, patient had the following side effects: abortion missed, abortion spontaneous, blighted ovum on Oct 28, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 36 years of age, weighting 123.5 lb, was diagnosed with phobia (What is phobia?), malaria prophylaxis and. Emla dosage: . During the same period patient was treated with MALARONE (One Tablet Daily) (View Malarone Review and Malarone Label ).

6295972-7 | Cyanosis Central
Adverse event was reported on Jul 27, 2009 by a Male patient taking Emla (View Usage) (Dosage: Application Of Half Patch Of Emla On Each Thigh) was diagnosed with local anaesthesia, immunisation and. Location: FRANCE , weighting 13.23 lb, Patient experienced the following unwanted or unexpected effects: cyanosis central. During the same period patient was treated with INFANRIX HEXA (View Infanrix Hexa Review and Infanrix Hexa Label ), PREVENAR (View Prevenar Review and Prevenar Label ).

6286490-0 | Inadequate Analgesia, Product Substitution Issue
on Jul 27, 2009 Female patient from UNITED STATES , 81 years of age, weighting 164.2 lb, was diagnosed with haemodialysis, pain management and was treated with Emla (View Usage). Patient had the following side effects: inadequate analgesia, product substitution issue. Emla dosage: .

6272615-X | Bradycardia, Syncope
on Jul 08, 2009 Male patient from SWITZERLAND , child 4 years of age, weighting 39.68 lb, was diagnosed with molluscum contagiosum and was treated with Emla (View Usage). After Emla was administered, patient had the following side effects: bradycardia, syncope. Emla dosage: . Patient was hospitalized.

6268935-5 | Blood Methaemoglobin, Cyanosis, Fatigue, Overdose
Patient was taking Emla (View Usage). Patient experienced the following unwanted or unexpected effects: blood methaemoglobin, cyanosis, fatigue, overdose on Jul 06, 2009 from AUSTRALIA Additional patient health information: Female patient , 44 years of age, was diagnosed with therapeutic skin care topical and. Emla dosage: . Patient was hospitalized.

6242445-3 | Ataxia, Muscular Weakness
Adverse event was reported on Jun 18, 2009 by a Female patient taking Emla (View Usage) (Dosage: ) was diagnosed with local anaesthesia, immunisation and. Location: FRANCE , weighting 22.05 lb, Patient had the following side effects: ataxia (What is ataxia?), muscular weakness. During the same period patient was treated with INFANRIX (View Infanrix Review and Infanrix Label ), PREVENAR (View Prevenar Review and Prevenar Label ).

6129137-6 | Body Temperature Increased, Erythema, Paraesthesia Oral
on Mar 23, 2009 Female patient from UNITED STATES , child 6 years of age, weighting 49.00 lb, was diagnosed with blood immunoglobulin g decreased and was treated with Emla (View Usage). After Emla was administered, patient had the following side effects: body temperature increased, erythema, paraesthesia oral. Emla dosage: Prior To Viva-infusion.

6111284-6 | Discomfort, Hypoaesthesia Facial
on Mar 10, 2009 Female patient from UNITED STATES , 35 years of age, weighting 116.8 lb, was diagnosed with local anaesthesia and was treated with Emla (View Usage). Patient experienced the following unwanted or unexpected effects: discomfort, hypoaesthesia facial. Emla dosage: Over One Hour.

6105797-0 | Burns Second Degree, Skin Hypopigmentation
Patient was taking Emla (View Usage). Patient had the following side effects: burns second degree, skin hypopigmentation on Feb 25, 2009 from TURKEY Additional patient health information: Female patient , 25 years of age, was diagnosed with anaesthesia and. Emla dosage: . Patient was hospitalized.

6101514-9 | Methaemoglobinaemia, Overdose
Adverse event was reported on Feb 24, 2009 by a Male patient taking Emla (View Usage) (Dosage: ) was diagnosed with local anaesthesia, pain (What is pain?), grand mal convulsion and. Location: GERMANY , weighting 24.25 lb, After Emla was administered, patient had the following side effects: methaemoglobinaemia, overdose. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), ESKETAMINE (View Esketamine Review and Esketamine Label ), ELECTROLYTE SOLUTIONS (View Electrolyte Solutions Review and Electrolyte Solutions Label ), GLUCOSE SOLUTION (View Glucose Solution Review and Glucose Solution Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ). Patient was hospitalized.

6068929-9 | Cyanosis, Fatigue, Methaemoglobinaemia
on Jan 30, 2009 Female patient from AUSTRALIA , 44 years of age, was treated with Emla (View Usage). Patient experienced the following unwanted or unexpected effects: cyanosis, fatigue, methaemoglobinaemia. Emla dosage: Three Large Tubes Of 30g (2.250g Lidocaine And 2.250g Prilocaine). Patient was hospitalized.

6065603-X | Accidental Overdose, Anxiety, Cyanosis, Depressed Level Of Consciousness, Dizziness, Dyspnoea, Hypoaesthesia Oral, Methaemoglobinaemia, Oxygen Saturation Decreased
on Jan 28, 2009 Female patient from CANADA , weighting 95.90 lb, was diagnosed with surgery (What is surgery?) and was treated with Emla (View Usage). Patient had the following side effects: accidental overdose, anxiety (What is anxiety?), cyanosis, depressed level of consciousness, dizziness (What is dizziness?), dyspnoea, hypoaesthesia oral, methaemoglobinaemia, oxygen saturation decreased. Emla dosage: .

6065270-5 | Chest Discomfort, Methaemoglobinaemia, Syncope
Patient was taking Emla (View Usage). After Emla was administered, patient had the following side effects: chest discomfort, methaemoglobinaemia, syncope on Jan 28, 2009 from CANADA Additional patient health information: Female patient , 29 years of age, weighting 110.2 lb, . Emla dosage: . Patient was hospitalized.

6064989-X | Cyanosis, Dizziness, Heart Rate Increased, Methaemoglobinaemia
Adverse event was reported on Jan 22, 2009 by a Female patient taking Emla (View Usage) (Dosage: ) . Location: CANADA , 36 years of age, Patient experienced the following unwanted or unexpected effects: cyanosis, dizziness (What is dizziness?), heart rate increased, methaemoglobinaemia.

6058506-8 | Cyanosis, Dizziness, Heart Rate Increased, Methaemoglobinaemia
on Jan 28, 2009 Female patient from CANADA , 36 years of age, was treated with Emla (View Usage). Patient had the following side effects: cyanosis, dizziness (What is dizziness?), heart rate increased, methaemoglobinaemia. Emla dosage: 90gram.

6041706-0 | Blood Methaemoglobin, Haemoglobin Decreased, Lethargy, Pallor
on Jan 15, 2009 Male patient from CANADA , weighting 11.02 lb, was treated with Emla (View Usage). After Emla was administered, patient had the following side effects: blood methaemoglobin, haemoglobin decreased, lethargy, pallor. Emla dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), ZINC OXIDE (View Zinc Oxide Review and Zinc Oxide Label ). Patient was hospitalized.

6039766-6 | Blood Methaemoglobin Present, Crying, Haemoglobin Decreased, Lip Discolouration, Malaise, Pallor, Rash, Scab
Patient was taking Emla (View Usage). Patient experienced the following unwanted or unexpected effects: blood methaemoglobin present, crying, haemoglobin decreased, lip discolouration, malaise, pallor, rash (What is rash?), scab (What is scab?) on Jan 15, 2009 from CANADA Additional patient health information: Male patient , weighting 11.02 lb, . Emla dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), CORTISONE ACETATE TAB (View Cortisone Acetate Tab Review and Cortisone Acetate Tab Label ), LIDOCAINE 2% (View Lidocaine 2% Review and Lidocaine 2% Label ).

5954845-7 | Application Site Oedema, Application Site Pruritus, Application Site Reaction
Adverse event was reported on Nov 06, 2008 by a Male patient taking Emla (View Usage) (Dosage: ) . Location: SPAIN , child 4 years of age, Patient had the following side effects: application site oedema, application site pruritus, application site reaction.

5859458-3 | Application Site Rash
on Aug 26, 2008 Female patient from UNITED STATES , weighting 1.57 lb, was treated with Emla (View Usage). After Emla was administered, patient had the following side effects: application site rash. Emla dosage: .

5829087-6 | Methaemoglobinaemia, Overdose
on Jul 24, 2008 Female patient from SPAIN , child 11 years of age, was diagnosed with anaesthesia and was treated with Emla (View Usage). Patient experienced the following unwanted or unexpected effects: methaemoglobinaemia, overdose. Emla dosage: . Patient was hospitalized.

5807255-7 | Methaemoglobinaemia, Overdose
Patient was taking Emla (View Usage). Patient had the following side effects: methaemoglobinaemia, overdose on Jul 09, 2008 from SPAIN Additional patient health information: Male patient , weighting 37.48 lb, was diagnosed with local anaesthesia and. Emla dosage: . Patient was hospitalized.

5707350-7 | Laryngeal Oedema, Urticaria
Adverse event was reported on Apr 07, 2008 by a Male patient taking Emla (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: FRANCE , weighting 41.45 lb, After Emla was administered, patient had the following side effects: laryngeal oedema, urticaria. During the same period patient was treated with D.T. POLIO (View D.t. Polio Review and D.t. Polio Label ). Patient was hospitalized.

5691874-5 | Crying
on Mar 25, 2008 Female patient from FRANCE , weighting 12.57 lb, was diagnosed with local anaesthesia, immunisation and was treated with Emla (View Usage). Patient experienced the following unwanted or unexpected effects: crying. Emla dosage: Half Patch On Each Leg. During the same period patient was treated with PREVENAR (Injection Into The Left Thigh) (View Prevenar Review and Prevenar Label ), PENTAVAC (View Pentavac Review and Pentavac Label ).

5526716-1 | Dermatitis Allergic
on Nov 20, 2007 Male patient from BELGIUM , child 5 years of age, weighting 37.48 lb, was diagnosed with molluscum contagiosum, gastrooesophageal reflux disease and was treated with Emla (View Usage). Patient had the following side effects: dermatitis allergic. Emla dosage: A Full Tube. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

5455979-6 | Overdose, Rash, Somnolence, Yawning
Patient was taking Emla (View Usage). After Emla was administered, patient had the following side effects: overdose, rash (What is rash?), somnolence, yawning on Sep 10, 2007 from FRANCE Additional patient health information: Female patient , child 3 years of age, weighting 33.07 lb, was diagnosed with local anaesthesia and. Emla dosage: . Patient was hospitalized.

5375421-3 | Arrhythmia, Circulatory Collapse, Cyanosis, Methaemoglobinaemia, Paraesthesia Oral, Tinnitus
Adverse event was reported on Jun 14, 2007 by a Female patient taking Emla (View Usage) (Dosage: Topical) was diagnosed with anaesthesia and. Location: EGYPT , 37 years of age, Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), circulatory collapse, cyanosis, methaemoglobinaemia, paraesthesia oral, tinnitus (What is tinnitus?). Patient was hospitalized.

5334880-2 | Circulatory Collapse, Dizziness, Nausea
on May 16, 2007 Male patient from GERMANY , weighting 66.14 lb, was diagnosed with molluscum contagiosum and was treated with Emla (View Usage). Patient had the following side effects: circulatory collapse, dizziness (What is dizziness?), nausea (What is nausea?). Emla dosage: .

5334874-7 | Circulatory Collapse, Dizziness, Nausea
on May 16, 2007 Male patient from GERMANY , weighting 66.14 lb, was diagnosed with molluscum contagiosum and was treated with Emla (View Usage). After Emla was administered, patient had the following side effects: circulatory collapse, dizziness (What is dizziness?), nausea (What is nausea?). Emla dosage: .

5281323-3 | Burning Sensation, Skin Hyperpigmentation, Skin Swelling
Patient was taking Emla (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, skin hyperpigmentation, skin swelling on Jun 14, 2004 from UNITED STATES Additional patient health information: Female patient , 29 years of age, . Emla dosage: . During the same period patient was treated with EFFEXOR (View Effexor Review and Effexor Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), BUSPAR (View Buspar Review and Buspar Label ), RISPERDAL (View Risperdal Review and Risperdal Label ).

5281322-1 | Convulsion
Adverse event was reported on Jul 15, 2005 by a Female patient taking Emla (View Usage) (Dosage: Every Other Week, Sometimes Every Two To Three Weeks) was diagnosed with blood electrolytes and. Location: UNITED STATES , 57 years of age, Patient had the following side effects: convulsion.

5239523-4 | Cyanosis, Somnolence
on Feb 07, 2007 Female patient from SPAIN , 23 years of age, weighting 121.3 lb, was treated with Emla (View Usage). After Emla was administered, patient had the following side effects: cyanosis, somnolence. Emla dosage: .

5227274-1 | Methaemoglobinaemia, Nervous System Disorder, Overdose
on Jan 22, 2007 Female patient from SPAIN , child 4 years of age, was diagnosed with pain prophylaxis and was treated with Emla (View Usage). Patient experienced the following unwanted or unexpected effects: methaemoglobinaemia, nervous system disorder, overdose. Emla dosage: .

5161135-1 | Application Site Hypersensitivity, Application Site Infection, Penile Swelling, Psychotic Disorder
Patient was taking Emla (View Usage). Patient had the following side effects: application site hypersensitivity, application site infection, penile swelling, psychotic disorder (What is psychotic disorder?) on Jul 11, 2006 from GERMANY Additional patient health information: Male patient , weighting 41.89 lb, was diagnosed with anaesthesia, wound complication and. Emla dosage: . Patient was hospitalized and became disabled.

5144910-9 | Application Site Vesicles
Adverse event was reported on Oct 31, 2006 by a Male patient taking Emla (View Usage) (Dosage: ) was diagnosed with local anaesthesia and. Location: NETHERLANDS , 62 years of age, After Emla was administered, patient had the following side effects: application site vesicles.

5097397-9 | Hypersensitivity, Infection, Psychotic Disorder, Urinary Retention
on Jul 11, 2006 Male patient from GERMANY , weighting 41.89 lb, was diagnosed with anaesthesia, wound complication and was treated with Emla (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, infection (What is infection?), psychotic disorder (What is psychotic disorder?), urinary retention. Emla dosage: . Patient was hospitalized and became disabled.

5096332-7 | Cyanosis, Depressed Level Of Consciousness, Methaemoglobinaemia, Overdose, Respiratory Distress
on Aug 29, 2006 Male patient from SWITZERLAND , child 4 years of age, was treated with Emla (View Usage). Patient had the following side effects: cyanosis, depressed level of consciousness, methaemoglobinaemia, overdose, respiratory distress. Emla dosage: 30 G Tube Applied.

5090071-4 | Coma, Methaemoglobinaemia, Overdose
Patient was taking Emla (View Usage). After Emla was administered, patient had the following side effects: coma, methaemoglobinaemia, overdose on Aug 21, 2006 from NETHERLANDS Additional patient health information: Female patient , child 2 years of age, was diagnosed with anaesthesia and. Emla dosage: . Patient was hospitalized.

5062513-1 | Delayed Recovery From Anaesthesia, Depressed Level Of Consciousness, Erythema, Methaemoglobinaemia, Skin Reaction
Adverse event was reported on Jul 17, 2006 by a Male patient taking Emla (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: PORTUGAL , child 4 years of age, Patient experienced the following unwanted or unexpected effects: delayed recovery from anaesthesia, depressed level of consciousness, erythema, methaemoglobinaemia, skin reaction. Patient was hospitalized.

5050438-7 | Blister, Dermatitis Bullous, Erythema, Haemorrhage
on May 09, 2006 Female patient from GERMANY , weighting 66.14 lb, was diagnosed with local anaesthesia, eczema (What is eczema?) and was treated with Emla (View Usage). Patient had the following side effects: blister, dermatitis bullous, erythema, haemorrhage. Emla dosage: . During the same period patient was treated with ADVANTAN (View Advantan Review and Advantan Label ).

5027931-6 | Cyanosis, Methaemoglobinaemia
on Jun 06, 2006 Female patient from SPAIN , 14 years of age, weighting 136.7 lb, was treated with Emla (View Usage). After Emla was administered, patient had the following side effects: cyanosis, methaemoglobinaemia. Emla dosage: .

5002895-X | Dermatitis Bullous
Patient was taking Emla (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous on May 09, 2006 from GERMANY Additional patient health information: Female patient , child 8 years of age, was diagnosed with local anaesthesia and. Emla dosage: .

5000984-7 | Corneal Erosion, Eye Pain
Adverse event was reported on Apr 20, 2006 by a Female patient taking Emla (View Usage) (Dosage: ) was diagnosed with local anaesthesia and. Location: BELGIUM , 33 years of age, Patient had the following side effects: corneal erosion, eye pain.

4933122-7 | Bradycardia, Hyperhidrosis, Hypotension, Syncope Vasovagal
on Feb 28, 2006 Male patient from FRANCE , child 10 years of age, was diagnosed with local anaesthesia and was treated with Emla (View Usage). After Emla was administered, patient had the following side effects: bradycardia, hyperhidrosis, hypotension, syncope vasovagal. Emla dosage: .

4883629-6 | Methaemoglobinaemia, Overdose
on Jun 28, 2004 Male patient from FRANCE , 25 years of age, weighting 176.4 lb, was diagnosed with local anaesthesia and was treated with Emla (View Usage). Patient experienced the following unwanted or unexpected effects: methaemoglobinaemia, overdose. Emla dosage: . Patient was hospitalized.

4862288-2 | Bradycardia, Overdose, Somnolence
Patient was taking Emla (View Usage). Patient had the following side effects: bradycardia, overdose, somnolence on Sep 27, 2005 from CANADA Additional patient health information: Male patient , child 5 years of age, was diagnosed with immunisation and. Emla dosage: .